Imagion Biosystems Limited (IBX.AX)
AUD 0.02
(5.56%)
AUD 0.02
(5.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.31 Million | -8.7 Million | -5.06 Million | -4.62 Million | -4.18 Million | -8.13 Million |
| Net Income | -12.47 Million | -9.8 Million | -6.02 Million | -5.36 Million | -3.43 Million | -8.34 Million |
| Depreciation & Amortization | 1.18 Million | 1.1 Million | 404.43 Thousand | 360.57 Thousand | 141.98 Thousand | 213.79 Thousand |
| Deferred income taxes | - | -9.32 Million | -1.25 Million | -1.39 Million | 512.77 Thousand | - |
| Stock-based compensation | 462.71 Thousand | 653.05 Thousand | 497.53 Thousand | 423.57 Thousand | -1.05 Million | 837.13 Thousand |
| Change in working capital | 2.15 Million | -29.66 Thousand | 48.05 Thousand | -252.04 Thousand | -319.8 Thousand | 614.53 Thousand |
| Other non-cash items | 1.03 Million | 8.7 Million | 1.26 Million | 1.6 Million | -26.53 Thousand | 8.13 Million |
| Investing Cash Flow | -190.37 Thousand | -468.72 Thousand | -310.09 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Investments in PPE | -190.37 Thousand | -507.31 Thousand | -218.83 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 38.58 Thousand | -91.26 Thousand | - | - | - |
| Financing Cash Flow | 4.29 Million | -962.06 Thousand | 5.14 Million | 14.52 Million | 3.32 Million | 4.1 Million |
| Debt repayment | -3.5 Million | -964.82 Thousand | -359.25 Thousand | -480.62 Thousand | -35.39 Thousand | -128.49 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -6109.00 | -1.34 Million | -13.3 Thousand | -54.18 Thousand |
| Common Stock Issuance | 5.26 Million | 2759.00 | 5.51 Million | 16.1 Million | 3.37 Million | 4.28 Million |
| Other Financing Activities | -1.59 Million | -964.82 Thousand | 359.25 Thousand | 714.43 Thousand | 35.39 Thousand | -128.49 Thousand |
| Accounts receivables | 370.74 Thousand | -197.67 Thousand | -34.13 Thousand | -66 Thousand | 24.19 Thousand | -44.58 Thousand |
| Accounts payables | 1.78 Million | 168.01 Thousand | 82.18 Thousand | -186.04 Thousand | -298.9 Thousand | 371.45 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | -45.09 Thousand | 287.67 Thousand |
| Cash at beginning of period | 4.44 Million | 13.39 Million | 13.2 Million | 3.4 Million | 4.36 Million | 6.87 Million |
| Cash at end of period | 227.08 Thousand | 4.44 Million | 13.39 Million | 13.2 Million | 3.4 Million | 4.36 Million |
| Capital Expenditure | -190.37 Thousand | -507.31 Thousand | -218.83 Thousand | -7860.00 | -12.35 Thousand | -83.56 Thousand |
| Effect of forex changes on cash | -4236.00 | 557.33 Thousand | 425.76 Thousand | -90.95 Thousand | -96.7 Thousand | 41.84 Thousand |
| Net cash flow / Change in cash | -4.21 Million | -8.94 Million | 193.22 Thousand | 9.79 Million | -965.38 Thousand | -2.5 Million |
| Free Cash Flow | -8.5 Million | -9.2 Million | -5.28 Million | -4.63 Million | -4.19 Million | -8.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -763.41 Thousand | -763.41 Thousand | -12.47 Million | -4.79 Million | -2.39 Million | -7.68 Million |
| Depreciation & Amortization | 192.15 Thousand | 192.15 Thousand | 1.18 Million | 598.76 Thousand | 299.38 Thousand | 584.48 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 462.71 Thousand | 108.69 Thousand | 108.69 Thousand | 122.66 Thousand |
| Change in working capital | - | - | 2.15 Million | 185.37 Thousand | 185.37 Thousand | - |
| Other non-cash items | 492.78 Thousand | 492.78 Thousand | 1.03 Million | 3.09 Million | 653.77 Thousand | 2.24 Million |
| Investing Cash Flow | 41.87 Thousand | 41.87 Thousand | -190.37 Thousand | -166.85 Thousand | -83.42 Thousand | -23.52 Thousand |
| Investments in PPE | 2.00 | - | -190.37 Thousand | -166.85 Thousand | -83.42 Thousand | -23.52 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 41.87 Thousand | 41.87 Thousand | - | - | - | - |
| Financing Cash Flow | 110 Thousand | 110 Thousand | 4.29 Million | 2.26 Million | 1.13 Million | 2.02 Million |
| Debt repayment | -220 Thousand | - | -3.5 Million | -2.5 Million | - | -2.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 5.26 Million | 5.19 Million | - | 70.26 Thousand |
| Other Financing Activities | 110 Thousand | 110 Thousand | -1.59 Million | 1.13 Million | 1.13 Million | 1.01 Million |
| Accounts receivables | - | - | 370.74 Thousand | 185.37 Thousand | 185.37 Thousand | - |
| Accounts payables | - | - | 1.78 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 227.08 Thousand | - | 4.44 Million | 453.56 Thousand | - | 4.44 Million |
| Cash at end of period | 382.45 Thousand | 77.68 Thousand | 227.08 Thousand | 227.08 Thousand | -113.23 Thousand | 453.56 Thousand |
| Capital Expenditure | 2.00 | - | -190.37 Thousand | -166.85 Thousand | -83.42 Thousand | -23.52 Thousand |
| Effect of forex changes on cash | 4282.00 | 4282.00 | -4236.00 | -16.38 Thousand | -16.38 Thousand | 14.27 Thousand |
| Net cash flow / Change in cash | 155.36 Thousand | 77.68 Thousand | -4.21 Million | -226.47 Thousand | -113.23 Thousand | -3.99 Million |
| Free Cash Flow | -78.46 Thousand | -78.47 Thousand | -8.5 Million | -2.46 Million | -1.23 Million | -6.04 Million |
EQ
FCTI
INPAP
002805
603381
1030